205 related articles for article (PubMed ID: 27307047)
21. Melanoma in congenital melanocytic naevi.
Kinsler VA; O'Hare P; Bulstrode N; Calonje JE; Chong WK; Hargrave D; Jacques T; Lomas D; Sebire NJ; Slater O
Br J Dermatol; 2017 May; 176(5):1131-1143. PubMed ID: 28078671
[TBL] [Abstract][Full Text] [Related]
22. A Symmetric Eczematous Eruption Harboring Thousands of Melanocytic Lesions.
Ratushny V; Kraft S; Moschella SL; Duncan LM; Lawrence DP; Tsao H
JAMA Dermatol; 2016 Sep; 152(9):1021-4. PubMed ID: 27192392
[TBL] [Abstract][Full Text] [Related]
23. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.
Mochel MC; Hammond MR; Frederick DT; Alora-Palli MB; Piris A; Flaherty KT; Hoang MP
J Am Acad Dermatol; 2015 Sep; 73(3):491-9.e2. PubMed ID: 26190239
[TBL] [Abstract][Full Text] [Related]
24. Novel genetic alteration in congenital melanocytic nevus: MAP2K1 germline mutation with BRAF somatic mutation.
Zou Y; Sun Y; Zeng X; Liu Y; Cen Q; Gu H; Lin X; Cai R; Chen H
Hereditas; 2020 Aug; 157(1):35. PubMed ID: 32847629
[TBL] [Abstract][Full Text] [Related]
25. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
26. Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies.
Price HN; Schaffer JV
Clin Dermatol; 2010; 28(3):293-302. PubMed ID: 20541682
[TBL] [Abstract][Full Text] [Related]
27. Genetic alterations in melanocytic tumors.
Takata M; Saida T
J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
[TBL] [Abstract][Full Text] [Related]
28. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
Polubothu S; McGuire N; Al-Olabi L; Baird W; Bulstrode N; Chalker J; Josifova D; Lomas D; O'Hara J; Ong J; Rampling D; Stadnik P; Thomas A; Wedgeworth E; Sebire NJ; Kinsler VA
Br J Dermatol; 2020 Feb; 182(2):434-443. PubMed ID: 31111470
[TBL] [Abstract][Full Text] [Related]
29. Acquired dysplastic melanocytic nevi and cutaneous melanoma: precursors and prevention.
Rhodes AR
Ann Intern Med; 1985 Apr; 102(4):546-8. PubMed ID: 3977199
[No Abstract] [Full Text] [Related]
30. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
[TBL] [Abstract][Full Text] [Related]
31. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
32. MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma.
Orouji E; Orouji A; Gaiser T; Larribère L; Gebhardt C; Utikal J
Int J Cancer; 2016 May; 138(9):2257-62. PubMed ID: 26684394
[TBL] [Abstract][Full Text] [Related]
33.
Ponti G; Manfredini M; Greco S; Pellacani G; Depenni R; Tomasi A; Maccaferri M; Cascinu S
Anticancer Res; 2017 Dec; 37(12):7043-7048. PubMed ID: 29187493
[TBL] [Abstract][Full Text] [Related]
34. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
35.
Bansal N; Das M; Chatterjee U; Mallick MG; Arora N; Mishra DK
Indian J Pathol Microbiol; 2021; 64(2):402-405. PubMed ID: 33851646
[TBL] [Abstract][Full Text] [Related]
36. Prepubertal Melanoma Arising within a Medium-Sized Congenital Melanocytic Nevus.
Lalor L; Busam K; Shah K
Pediatr Dermatol; 2016 Nov; 33(6):e372-e374. PubMed ID: 27573553
[TBL] [Abstract][Full Text] [Related]
37. The association of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children.
Chen J; Zhang G; Liu X; Tu P
An Bras Dermatol; 2023; 98(4):498-505. PubMed ID: 37156689
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic and mutational analyses of melanocytic tumors.
Gerami P; Busam KJ
Dermatol Clin; 2012 Oct; 30(4):555-66, v. PubMed ID: 23021045
[TBL] [Abstract][Full Text] [Related]
40. Mutation stability in primary and metastatic melanoma: what we know and what we don't.
Varada S; Mahalingam M
Histol Histopathol; 2015 Jul; 30(7):763-70. PubMed ID: 25585249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
